Total Payments
$8,723
2024 Payments
$1,098
Companies
48
Transactions
432
Medicare Patients
8,108
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$7,976 (91.4%)
Education$702.60 (8.1%)
Other$45.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,976 | 408 | 91.4% |
| Education | $702.60 | 23 | 8.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,235 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,209 | 53 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $533.57 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $531.46 | 32 | $0 (2024) |
| Vifor Pharma, Inc. | $416.08 | 18 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $399.80 | 23 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $373.58 | 16 | $0 (2023) |
| Horizon Therapeutics plc | $330.74 | 18 | $0 (2023) |
| Novo Nordisk Inc | $292.92 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $291.80 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,098 | 48 | Amgen Inc. ($183.09) |
| 2023 | $1,752 | 73 | Calliditas Therapeutics US Inc. ($207.06) |
| 2022 | $1,325 | 69 | Amgen Inc. ($229.56) |
| 2021 | $1,034 | 57 | Vifor Pharma, Inc. ($179.37) |
| 2020 | $1,041 | 52 | AstraZeneca Pharmaceuticals LP ($331.60) |
| 2019 | $719.27 | 42 | AstraZeneca Pharmaceuticals LP ($120.43) |
| 2018 | $1,082 | 52 | Amgen Inc. ($202.64) |
| 2017 | $670.24 | 39 | Amgen Inc. ($205.95) |
All Payment Transactions
432 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEPHROLOGY | ||||||
| 05/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Nephrology | ||||||
| 04/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 04/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Diabetes | ||||||
| 04/22/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Hyperkalemia | ||||||
| 04/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Inflammation | ||||||
| 04/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Inflammation | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/09/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.02 | General |
| Category: NEPHROLOGY | ||||||
| 04/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Hyperkalemia | ||||||
| 03/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardio-renal | ||||||
| 03/25/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.89 | General |
| 03/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEPHROLOGY | ||||||
| 03/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,747 | 3,047 | $824,925 | $369,796 |
| 2022 | 19 | 1,766 | 3,065 | $814,397 | $359,766 |
| 2021 | 24 | 2,254 | 4,248 | $1.2M | $546,894 |
| 2020 | 25 | 2,341 | 4,066 | $1.1M | $416,363 |
Total Patients
8,108
Total Services
14,426
Medicare Billing
$1.7M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 174 | 393 | $242,190 | $117,122 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 344 | 677 | $157,408 | $70,395 | 44.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 148 | 314 | $68,320 | $31,711 | 46.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 225 | 444 | $67,177 | $29,815 | 44.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 30 | 72 | $36,791 | $17,849 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 231 | $36,218 | $17,049 | 47.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 105 | $44,451 | $15,452 | 34.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 49 | 59 | $30,292 | $14,643 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 78 | $24,186 | $11,947 | 49.4% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2023 | 70 | 135 | $35,100 | $11,560 | 32.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 71 | 78 | $22,491 | $8,637 | 38.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 76 | 140 | $28,017 | $8,455 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $20,967 | $8,117 | 38.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 17 | $5,950 | $3,958 | 66.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 219 | $2,190 | $1,831 | 83.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,047 | $1,213 | 39.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $130.00 | $44.33 | 34.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 186 | 350 | $215,588 | $107,092 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 309 | 661 | $153,090 | $68,315 | 44.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 322 | 662 | $100,390 | $40,209 | 40.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 157 | 272 | $59,198 | $23,730 | 40.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 80 | 92 | $47,235 | $23,312 | 49.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 30 | 66 | $33,725 | $16,120 | 47.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 93 | 95 | $40,217 | $16,052 | 39.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 96 | 109 | $31,564 | $12,604 | 39.9% |
About Dr. Paul Feldman, MD
Dr. Paul Feldman, MD is a Internal Medicine healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497844757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Feldman, MD has received a total of $8,723 in payments from pharmaceutical and medical device companies, with $1,098 received in 2024. These payments were reported across 432 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,976).
As a Medicare-enrolled provider, Feldman has provided services to 8,108 Medicare beneficiaries, totaling 14,426 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Newburgh, NY
- Active Since 10/12/2006
- Last Updated 09/30/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497844757
Products in Payments
- Veltassa (Drug) $689.88
- ACTHAR (Biological) $635.52
- LOKELMA (Drug) $609.66
- Velphoro (Drug) $533.57
- FARXIGA (Drug) $453.77
- KRYSTEXXA (Biological) $422.31
- JYNARQUE (Drug) $379.75
- Parsabiv (Drug) $288.24
- Parsabiv (Biological) $279.03
- PURIFIED CORTROPHIN GEL (Drug) $259.44
- TARPEYO (Drug) $222.30
- RAYALDEE (Drug) $207.31
- Kerendia (Drug) $201.63
- JESDUVROQ (Drug) $191.89
- GATTEX (Drug) $184.81
- Rayaldee (Drug) $175.62
- TAVNEOS (Drug) $157.65
- Ozempic (Drug) $156.90
- SAMSCA (Drug) $136.62
- Prolia (Biological) $135.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newburgh
Mohammed Allaw, M.d, M.D
Internal Medicine — Payments: $45,650
Internal Medicine $45,650
Dr. Maruthi Penumetsa, Md, MD
Internal Medicine — Payments: $42,696
Internal Medicine $42,696
Ward Neff, M.d, M.D
Internal Medicine — Payments: $9,402
Internal Medicine $9,402
Uticia Belfield, M.d, M.D
Internal Medicine — Payments: $8,682
Internal Medicine $8,682
Dr. Manga Kodali, M.d, M.D
Internal Medicine — Payments: $6,603
Internal Medicine $6,603
Michael Snyder, M.d, M.D
Internal Medicine — Payments: $5,442
Internal Medicine $5,442